CompletedNot Applicable

Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP

South Africa106 participantsStarted 2020-11-05

Plain-language summary

The postpartum PrEP study (PPS) seeks to evaluate how best to improve adherence to PrEP in postpartum women and to evaluate how acceptable it is to offer HIV self tests for the participant and partner, and provide enhanced adherence biofeedback following a urine test of recent PrEP use (measuring tenofovir). The primary outcome is recent PrEP adherence following the intervention. The secondary outcome is HIV testing uptake in participants' partners.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Currently enrolled in PrEP-PP study and on PrEP
✓. 18+ years old
✓. confirmed HIV-negative (confirmed with a 4th generation antigen HIV test)
✓. confirmed to be postpartum (1-6 months postpartum)
✓. confirmed to currently have a male partner
✓. confirmed to have a cell phone that can read and respond to SMS/Whatsapp messages

What they're measuring

Recent PrEP Adherence

Timeframe: 1 month after intervention

Trial details

NCT IDNCT04897737

SponsorUniversity of California, Los Angeles

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-04-30

Results submitted2022-03-04

View on ClinicalTrials.gov More HIV-1-infection trials